Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
246.90
-7.95 (-3.12%)
BSENSE

Aug 10

BSE+NSE Vol: 5.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 965190,
    "name": "Wanbury",
    "stock_name": "Wanbury",
    "full_name": "Wanbury Ltd",
    "name_url": "stocks-analysis/wanbury",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "246.90",
    "chg": -7.95,
    "chgp": "-3.12%",
    "dir": -1,
    "prev_price": "254.85",
    "mcapval": "893.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524212,
    "symbol": "WANBURY",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE107F01022",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "5.73 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/wanbury-965190-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Wanbury Ltd Valuation Shifts to Fair Amid Strong Fundamentals and Market Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-valuation-shifts-to-fair-amid-strong-fundamentals-and-market-outperformance-4002084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WanburyLtd_valuationdot_4002084.png",
        "date": "2026-05-21 08:01:23",
        "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a backdrop of strong operational metrics and a mixed valuation landscape within its peer group, prompting investors to reassess the stock’s price attractiveness relative to historical and sector benchmarks."
      },
      {
        "title": "Wanbury Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-surges-to-upper-circuit-on-robust-buying-momentum-4000987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WanburyLtd_stocks_hitting_upper_circuit_4000987.png",
        "date": "2026-05-20 11:00:14",
        "description": "At Rs 271, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Wanbury Ltd locked at its upper circuit of 5% on 20 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Wanbury Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Micro-Cap Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-micro-cap-surge-4000205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WanburyLtd_technicaldot_4000205.png",
        "date": "2026-05-20 08:04:26",
        "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, upgrading its outlook from mildly bullish to bullish. This change is underscored by a combination of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting renewed investor interest and potential upside in the near term."
      },
      {
        "title": "Wanbury Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-surges-to-upper-circuit-on-strong-buying-momentum-3989545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/WanburyLtd_stocks_hitting_upper_circuit_3989545.png",
        "date": "2026-05-13 12:00:06",
        "description": "At Rs 261.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Wanbury Ltd locked at its upper circuit of 5.0% on 12 May 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 15,
    "sid": "965190",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/wanbury-965190"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "03-Aug-2026",
      "details": "Wanbury Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Tuesday August 11 2026 inter-alia to consider and approve the Un-audited Financial Results for the first quarter and three months ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "30-Jul-2026",
      "details": "Press Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Companys Facility At Tanuku West Godavari District Andhra Pradesh",
      "datetime": "22-Jul-2026",
      "details": "Intimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Companys Facilty.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wanbury Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Jul 10",
          "dt": "2010-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

03-Aug-2026 | Source : BSE

Wanbury Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Tuesday August 11 2026 inter-alia to consider and approve the Un-audited Financial Results for the first quarter and three months ended June 30 2026.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

30-Jul-2026 | Source : BSE

Press Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs

Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Companys Facility At Tanuku West Godavari District Andhra Pradesh

22-Jul-2026 | Source : BSE

Intimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Companys Facilty.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

Wanbury Ltd has declared 10% dividend, ex-date: 29 Jul 10

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available